|
AMN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.655400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.878200E-02 |
| Normal-vs-Stage2 |
7.572000E-02 |
| Normal-vs-Stage3 |
4.275000E-01 |
| Normal-vs-Stage4 |
2.044100E-02 |
| Stage1-vs-Stage2 |
4.955200E-01 |
| Stage1-vs-Stage3 |
1.148000E-02 |
| Stage1-vs-Stage4 |
4.028000E-04 |
| Stage2-vs-Stage3 |
2.238300E-02 |
| Stage2-vs-Stage4 |
7.612300E-04 |
| Stage3-vs-Stage4 |
1.435010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.643200E-01 |
| Normal-vs-AfricanAmerican |
5.249600E-01 |
| Normal-vs-Asian |
2.519400E-01 |
| Caucasian-vs-AfricanAmerican |
4.793800E-01 |
| Caucasian-vs-Asian |
2.806000E-01 |
| AfricanAmerican-vs-Asian |
9.463600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.548000E-01 |
| Normal-vs-Female |
1.918210E-01 |
| Male-vs-Female |
8.397600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.524000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.345000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.135200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.487700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.321410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.368300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.178400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.531000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.526790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.451600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.835500E-04 |
| Classical-VS-Follicular |
2.459700E-03 |
| Classical-VS-Other |
8.148000E-01 |
| Classical-VS-Normal |
4.927800E-01 |
| Tall-VS-Follicular |
6.07539999974982E-07 |
| Tall-VS-Other |
8.640200E-02 |
| Tall-VS-Normal |
7.460400E-03 |
| Follicular-VS-Other |
1.778450E-02 |
| Follicular-VS-Normal |
1.696400E-03 |
| Other-VS-Normal |
8.686400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.621600E-01 |
| Normal-vs-N1 |
7.742400E-01 |
| N0-vs-N1 |
2.819600E-01 |
|
|
